Hofseth BioCare to codevelop delayed-release fish oil capsules

Norwegian biotech firm Hofseth BioCare (HBC) are to partner up with drug delivery specialists Catalent in an agreement that looks to develop a delayed-release formulation of HBC’s OmeGo salmon oil.

Related Keywords

China ,Aris Gennadios , ,Scientific Officer ,Oral Technologies ,Pod Duo ,Cosmopod Duo ,Suppliers ,Omega 3 ,Mega 3s Amp Nutritional Oils ,Hofseth ,Catalent ,Salmon Oil ,சீனா ,அறிவியல் அதிகாரி ,வாய்வழி தொழில்நுட்பங்கள் ,சப்ளையர்கள் ,